Efficiency and Complication of 577-nm Laser Membranotomy for the Treatment of Retinal Sub-Inner Limiting Membrane Hemorrhage

Yongpeng Zhang, Jipeng Li, Xusheng Cao, Haiying Zhou, Liyun Jia, Liqin Gao, Zhihua Li, Xifang Zhang, Haicheng She, Kai Ma, Xiaoyan PengFrontiers in Ophthalmology 2022 · DOI

TL;DR

This study investigates the efficacy and safety of using a 577-nm laser to treat sub-inner limiting membrane (sub-ILM) hemorrhages, a condition that can cause sudden vision loss. The 577-nm laser demonstrated a high success rate (94.74%) in clearing these hemorrhages, offering a less invasive treatment option. However, potential complications like macular holes and persistent vitreous hemorrhage necessitate careful monitoring and may require further intervention.

What Problem Does This Paper Address?

Sub-inner limiting membrane (sub-ILM) hemorrhage is a relatively uncommon but serious retinal condition that can lead to significant and rapid vision loss. Blood accumulating in the sub-ILM space can be slow to resorb, potentially causing irreversible retinal damage and long-term visual impairment. While various treatment options exist, including observation, laser therapy, and surgery, there's a need for more research on the clinical efficiency and safety of specific laser modalities for this condition. This paper aims to fill this gap by evaluating the 577-nm semiconductive laser, a tool increasingly used in ophthalmology, for treating sub-ILM hemorrhages.

Methods

This was a retrospective case-series study involving 19 patients (19 eyes) treated with a 577-nm semiconductive laser for sub-ILM hemorrhage at Beijing Tongren Hospital between January 2017 and April 2022. A comprehensive ophthalmologic examination, including best-corrected visual acuity (BCVA), slit-lamp examination, intraocular pressure, and ocular fundus examination, was performed before and after treatment. Fundus photography and spectral-domain optical coherence tomography (SD-OCT) were used to assess clinical features and treatment outcomes.

The 577-nm laser treatment parameters were as follows: wavelength of 577 nm, power from 300 to 500 mW, spot size of 200 µm, exposure time of 200 ms, and 1 to 14 laser spots. The laser application was targeted at the edge of the sub-ILM hemorrhage, approximately 200 µm away, to avoid damaging normal retinal tissue.

Datasets

Not discussed in the paper. The study analyzed data from 19 patients treated at a single institution.

Key Insights and Ideas

  • 577-nm Laser as a Viable Option: The study highlights the 577-nm laser as an effective and safe tool for treating sub-ILM hemorrhages, offering a high success rate. This is important because it provides a less invasive alternative to surgery for many patients.
  • Importance of Early Intervention: The paper suggests that the optimal time for laser treatment is within 21 days of hemorrhage onset, and delayed treatment (like the one outlier case at 60 days) can lead to failure. This underscores the time-sensitive nature of managing these hemorrhages.
  • Complications Require Vigilance: While successful, the treatment is not without risks. The occurrence of macular holes, epiretinal membranes, and persistent vitreous hemorrhage indicates that close post-treatment monitoring is crucial.
  • Sub-ILM Cavity Formation: A significant finding was the formation of sub-ILM cavities in 12 patients. While these didn't appear to immediately affect visual acuity, their long-term resolution and potential for complications warrant further investigation.
  • Age and ILM Position: The study observed a correlation between age and the post-treatment position of the inner limiting membrane (ILM). Older patients with vitreous liquefaction were more likely to have the ILM fall back to the retina, whereas younger patients with stickier vitreous were more prone to ILM not attaching.

Key Results

  • Success Rate: The 577-nm laser membranotomy was successful in 18 out of 19 patients, achieving a success rate of 94.74%.
  • Visual Acuity Improvement: BCVA improved in 16 out of 19 cases (84.21%). Initial BCVA ranged from finger count to 40/200, and post-treatment BCVA ranged from 20/2000 to 20/20.
  • Drainage Time: Immediate drainage was observed in 13 cases, and delayed drainage (starting 1 day later) in five cases. The average complete drainage time was 25.67 days, with a shorter average of 9 days when excluding longer cases.
  • Complications:
    • Macular hole: 1 patient
    • Macular epiretinal membrane: 1 patient
    • Vitreous hemorrhage without absorption: 2 patients
    • Sub-ILM cavity: 12 patients

Limitations and Future Work

The authors acknowledge several limitations:

  • Small Sample Size: The study included only 19 patients, which is a relatively small number.
  • Short Follow-up Period: The follow-up duration ranged from 0.5 to 9 months, which may not be sufficient to fully assess long-term outcomes and complications.
  • Lack of Control Group: The study did not include a control group of healthy volunteers or compare the 577-nm laser to other treatment modalities.

Future work should focus on:

  • Prospective and Randomized Trials: Conducting larger, prospective, and randomized trials are needed to validate the effectiveness and safety of the 577-nm laser.
  • Long-Term Monitoring: Extended follow-up periods are necessary to understand the long-term resolution of complications like sub-ILM cavities and the potential for recurrence.
  • Comparative Studies: Comparing the 577-nm laser with other treatment options (e.g., YAG laser, vitrectomy) would provide valuable insights into the optimal management strategy for sub-ILM hemorrhages.

Summary updated

Abstract

The 577-nm laser is effective in treating sub-ILM hemorrhage and has a high success rate. Posttreatment complications should be monitored, and vitrectomy was needed with long-lasting vitreous hemorrhage and macular hole.
BibTeX
@inproceedings{zhang2022efficiency,
  author = {Yongpeng Zhang and Jipeng Li and Xusheng Cao and Haiying Zhou and Liyun Jia and Liqin Gao and Zhihua Li and Xifang Zhang and Haicheng She and Kai Ma and Xiaoyan Peng},
  title = {{Efficiency and Complication of 577-nm Laser Membranotomy for the Treatment of Retinal Sub-Inner Limiting Membrane Hemorrhage}},
  booktitle = {Frontiers in Ophthalmology},
  year = {2022},
  doi = {10.3389/fopht.2022.935188},
}
Figure